| Bioactivity | Pantoprazole (sodium hydrate) (Standard) is the analytical standard of Pantoprazole (sodium hydrate). This product is intended for research and analytical applications. Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole sodium hydrate, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole sodium hydrate improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole sodium hydrate significantly increased tumor growth delay combined with Doxorubicin (HY-15142). |
| CAS | 164579-32-2 |
| Formula | C16H17F2N3NaO5.5S |
| Molar Mass | 432.37 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Pantoprazole sodium hydrate (Standard)
CAS: 164579-32-2 F: C16H17F2N3NaO5.5S W: 432.37
Pantoprazole (sodium hydrate) (Standard) is the analytical standard of Pantoprazole (sodium hydrate). This product is in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.